Antibody data
- Antibody Data
- Antigen structure
- References [10]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 22565-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- ELF1 antibody
- Antibody type
- Polyclonal
- Description
- ELF1 antibody (Cat. #22565-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references ETS transcription factor 1-insulin-like growth factor 2 mRNA-binding protein 2-interferon-induced transmembrane protein 3 pathway promotes ferroptosis-driven osteoblast senescence in diabetic osteoporosis.
METTL14-mediated m(6)A methylation of pri-miR-5099 to facilitate cardiomyocyte pyroptosis in myocardial infarction.
ARL11 knockdown alleviates spinal cord injury by inhibiting neuroinflammation and M1 activation of microglia in mice.
Pharmacological restriction of genomic binding sites redirects PU.1 pioneer transcription factor activity.
Overexpression of ELF1 combined with MMP9 is associated with prognosis and tumor microenvironment in gastric cancer.
Novel biomarkers to predict treatment response and prognosis in locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.
Divergent transcriptional regulation of astrocyte reactivity across disorders.
rs9459874 and rs1012656 in CCR6/FGFR1OP confer susceptibility to primary biliary cholangitis.
Let-7i-5p Regulation of Cell Morphology and Migration Through Distinct Signaling Pathways in Normal and Pathogenic Urethral Fibroblasts.
TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1.
Liu XW, Zhang SB, Xu HW, Lu JH, Chang SJ, Huang SS, Wang SJ
International journal of biological macromolecules 2026 Mar;350:150917
International journal of biological macromolecules 2026 Mar;350:150917
METTL14-mediated m(6)A methylation of pri-miR-5099 to facilitate cardiomyocyte pyroptosis in myocardial infarction.
Yu H, Li QS, Guo JN, Zhang Z, Lang XZ, Liu YN, Qin L, Su X, Zhang QW, Xue YD, Gong LL, Xu N, Li M, Zhao WS, Zhao XM, Zhang WY, Yao YJ, Chen XM, Zhang Z, Li W, Wang HX, Cai BZ, Li JM, Wang N
Acta pharmacologica Sinica 2025 Jun;46(6):1639-1651
Acta pharmacologica Sinica 2025 Jun;46(6):1639-1651
ARL11 knockdown alleviates spinal cord injury by inhibiting neuroinflammation and M1 activation of microglia in mice.
Zhang H, Xiang L, Yuan H, Yu H
Biochimica et biophysica acta. Molecular basis of disease 2025 Jan;1871(1):167522
Biochimica et biophysica acta. Molecular basis of disease 2025 Jan;1871(1):167522
Pharmacological restriction of genomic binding sites redirects PU.1 pioneer transcription factor activity.
Taylor SJ, Stauber J, Bohorquez O, Tatsumi G, Kumari R, Chakraborty J, Bartholdy BA, Schwenger E, Sundaravel S, Farahat AA, Wheat JC, Goldfinger M, Verma A, Kumar A, Boykin DW, Stengel KR, Poon GMK, Steidl U
Nature genetics 2024 Oct;56(10):2213-2227
Nature genetics 2024 Oct;56(10):2213-2227
Overexpression of ELF1 combined with MMP9 is associated with prognosis and tumor microenvironment in gastric cancer.
Zhang X, Ren X, Zhang S, Wang Y
Experimental and therapeutic medicine 2024 Dec;28(6):441
Experimental and therapeutic medicine 2024 Dec;28(6):441
Novel biomarkers to predict treatment response and prognosis in locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.
Guan B, Xu M, Zheng R, Guan G, Xu B
BMC cancer 2023 Nov 12;23(1):1099
BMC cancer 2023 Nov 12;23(1):1099
Divergent transcriptional regulation of astrocyte reactivity across disorders.
Burda JE, O'Shea TM, Ao Y, Suresh KB, Wang S, Bernstein AM, Chandra A, Deverasetty S, Kawaguchi R, Kim JH, McCallum S, Rogers A, Wahane S, Sofroniew MV
Nature 2022 Jun;606(7914):557-564
Nature 2022 Jun;606(7914):557-564
rs9459874 and rs1012656 in CCR6/FGFR1OP confer susceptibility to primary biliary cholangitis.
Hitomi Y, Aiba Y, Ueno K, Nishida N, Kawai Y, Kawashima M, Yasunami M, Gervais O, Ito M, Cordell HJ, Mells GF, Nagasaki M, Tokunaga K, Tsuiji M, Nakamura M
Journal of autoimmunity 2022 Jan;126:102775
Journal of autoimmunity 2022 Jan;126:102775
Let-7i-5p Regulation of Cell Morphology and Migration Through Distinct Signaling Pathways in Normal and Pathogenic Urethral Fibroblasts.
Zhang K, Yang R, Chen J, Qi E, Zhou S, Wang Y, Fu Q, Chen R, Fang X
Frontiers in bioengineering and biotechnology 2020;8:428
Frontiers in bioengineering and biotechnology 2020;8:428
TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1.
Pang Y, Zhao Y, Wang Y, Wang X, Wang R, Liu N, Li P, Ji M, Ye J, Sun T, Li J, Ma D, Lu F, Ji C
Journal of experimental & clinical cancer research : CR 2020 Aug 14;39(1):158
Journal of experimental & clinical cancer research : CR 2020 Aug 14;39(1):158
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- PC-3 cells were subjected to SDS PAGE followed by western blot with 22565-1-AP(ELF1 antibody) at dilution of 1:2000
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- The ELF1 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human ELF1. This antibody recognizes human, mouse antigen. The ELF1 antibody has been validated for the following applications: ELISA, WB, IHC analysis.